Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.18
+0.10 (0.83%)
Dec 20, 2024, 4:00 PM EST - Market closed
Intellia Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 120.5 | 226.75 | 523.51 | 123.41 | 160.02 | 57.23 | Upgrade
|
| Short-Term Investments | 537.62 | 685.48 | 669.12 | 625.28 | 437.35 | 222.5 | Upgrade
|
| Cash & Short-Term Investments | 658.11 | 912.22 | 1,193 | 748.69 | 597.37 | 279.73 | Upgrade
|
| Cash Growth | -23.01% | -23.51% | 59.29% | 25.33% | 113.56% | -10.93% | Upgrade
|
| Receivables | 8.85 | 36.46 | 3.77 | 2.03 | 2.13 | 4.62 | Upgrade
|
| Prepaid Expenses | 43.93 | 47.55 | 20.41 | 18.58 | 14.32 | 5.14 | Upgrade
|
| Restricted Cash | - | - | - | - | 2.7 | - | Upgrade
|
| Other Current Assets | - | 2.1 | - | - | - | - | Upgrade
|
| Total Current Assets | 710.9 | 998.33 | 1,217 | 769.3 | 616.52 | 289.48 | Upgrade
|
| Property, Plant & Equipment | 129.09 | 148.14 | 161 | 100.11 | 55.06 | 37.13 | Upgrade
|
| Long-Term Investments | 316.52 | 136.43 | 126.59 | 420.29 | 0.16 | 4.75 | Upgrade
|
| Other Long-Term Assets | 16.84 | 18.08 | 15.73 | 4.76 | 4.59 | 2.92 | Upgrade
|
| Total Assets | 1,173 | 1,301 | 1,520 | 1,294 | 676.32 | 334.28 | Upgrade
|
| Accounts Payable | 13.15 | 7.45 | 5.15 | 9.65 | 10.46 | 3.94 | Upgrade
|
| Accrued Expenses | 49.86 | 60.13 | 60.88 | 43.31 | 25.55 | 13.27 | Upgrade
|
| Current Portion of Leases | 19.18 | 18.6 | 16.69 | 9.11 | 5.7 | 5.75 | Upgrade
|
| Current Unearned Revenue | 22.16 | 22.14 | 43.84 | 63.76 | 22.54 | 12.67 | Upgrade
|
| Other Current Liabilities | 1.35 | 6.89 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 105.68 | 115.21 | 126.55 | 125.83 | 64.25 | 35.63 | Upgrade
|
| Long-Term Leases | 82.45 | 96.75 | 114.02 | 64.91 | 33.61 | 12.63 | Upgrade
|
| Long-Term Unearned Revenue | 22.61 | 38.85 | 19.93 | 63.48 | 51.39 | 16.14 | Upgrade
|
| Other Long-Term Liabilities | - | - | 24.03 | - | - | - | Upgrade
|
| Total Liabilities | 210.74 | 250.81 | 284.53 | 254.22 | 149.25 | 64.4 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 3,008 | 2,711 | 2,420 | 1,746 | 962.17 | 570.49 | Upgrade
|
| Retained Earnings | -2,049 | -1,658 | -1,177 | -703 | -435.11 | -300.88 | Upgrade
|
| Comprehensive Income & Other | 3.3 | -2.26 | -7.46 | -2.63 | 0 | 0.26 | Upgrade
|
| Total Common Equity | 962.62 | 1,050 | 1,236 | 1,040 | 527.07 | 269.88 | Upgrade
|
| Shareholders' Equity | 962.62 | 1,050 | 1,236 | 1,040 | 527.07 | 269.88 | Upgrade
|
| Total Liabilities & Equity | 1,173 | 1,301 | 1,520 | 1,294 | 676.32 | 334.28 | Upgrade
|
| Total Debt | 101.62 | 115.35 | 130.7 | 74.02 | 39.31 | 18.38 | Upgrade
|
| Net Cash (Debt) | 843.06 | 896.74 | 1,131 | 1,012 | 558.07 | 266.1 | Upgrade
|
| Net Cash Growth | -3.56% | -20.73% | 11.78% | 81.35% | 109.72% | -15.27% | Upgrade
|
| Net Cash Per Share | 8.78 | 10.10 | 14.70 | 14.28 | 9.97 | 5.63 | Upgrade
|
| Filing Date Shares Outstanding | 101.85 | 96.11 | 88.02 | 74.67 | 67.73 | 50.51 | Upgrade
|
| Total Common Shares Outstanding | 101.8 | 93 | 87.1 | 74.49 | 66.23 | 50.2 | Upgrade
|
| Working Capital | 605.22 | 883.12 | 1,090 | 643.47 | 552.26 | 253.85 | Upgrade
|
| Book Value Per Share | 9.46 | 11.29 | 14.19 | 13.97 | 7.96 | 5.38 | Upgrade
|
| Tangible Book Value | 962.62 | 1,050 | 1,236 | 1,040 | 527.07 | 269.88 | Upgrade
|
| Tangible Book Value Per Share | 9.46 | 11.29 | 14.19 | 13.97 | 7.96 | 5.38 | Upgrade
|
| Machinery | - | 67.59 | 56.33 | 43.34 | 32.7 | 29.37 | Upgrade
|
| Leasehold Improvements | - | 3.13 | 3.07 | 2.19 | 1.52 | 1.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.